Table 5.
Adjusted odds ratios of hyperuricemia among participants associated with total vitamin D intake.
| Total vitamin D intake (mcg/day) | p for trend | ||||||
|---|---|---|---|---|---|---|---|
| Q1 (<1.3) | Q2 (1.3–3.4) | Q3 (3.5–6.8) | Q4 (6.9–14.6) | Q5 (≥14.7) | |||
| (n = 1,515) | (n = 1,617) | (n = 1,606) | (n =1,598) | (n = 1,591) | |||
| Male (n = 7,927) | Model 1a | Reference | 0.86 (0.73, 1.01) | 0.75 (0.64, 0.89) | 0.71 (0.60, 0.84) | 0.62 (0.52, 0.73) | <0.0001 |
| Model 2b | Reference | 0.85 (0.72, 1.00) | 0.72 (0.61, 0.85) | 0.69 (0.59, 0.82) | 0.59 (0.49, 0.70) | <0.0001 | |
| Model 3c | Reference | 0.83 (0.69, 0.98) | 0.69 (0.58, 0.83) | 0.66 (0.55, 0.79) | 0.59 (0.48, 0.71) | <0.0001 | |
| Q1 (<1.2) | Q2 (1.2–3.2) | Q3 (3.3–7.2) | Q4 (7.3–19.5) | Q5 (≥19.6) | |||
| (n = 1,487) | (n = 1,579) | (n =1,609) | (n =1,557) | (n = 1,564) | |||
| Female (n = 7,796) | Model 1a | Reference | 0.98 (0.82, 1.16) | 0.78 (0.65, 0.93) | 0.74 (0.62, 0.89) | 0.71 (0.60, 0.85) | <0.0001 |
| Model 2b | Reference | 1.01 (0.85, 1.21) | 0.80 (0.67, 0.96) | 0.77 (0.64, 0.92) | 0.77 (0.64, 0.92) | 0.0001 | |
| Model 3c | Reference | 1.01 (0.84, 1.22) | 0.82 (0.68, 1.33) | 0.83 (0.68, 1.02) | 0.80 (0.65, 0.98) | 0.0076 | |
a
Adjusted for age, race/ethnicity;
b
adjusted for age, race/ethnicity, smoking status, drinking status, hypertension status and diabetes status;
c
adjusted for age, race/ethnicity, smoking status, drinking status, hypertension status, diabetes status, creatinine, STC, glucose, BMI, HDL-C, STG, serum calcium, magnesium intake, zinc intake, fiber intake.